The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.135
https://www.valueinhealthjournal.com/article/S1098-3015(17)30469-2/fulltext
Title :
The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30469-2&doi=10.1016/j.jval.2017.08.135
First page :
A421
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
117